STING1 and pancreatic neoplasm: Previous studies have shown that using vaccines containing STING agonists resulted in significant upregulation of PD-L1 in a mouse model of pancreatic cancer liver metastases, potentially sensitizing pancreatic cancer to ICIs [39].